2026 Katharina Buerger: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	61	3694	3377	320	299	292	12640

Overview

Katharina Buerger is affiliated with Ludwig-Maximilians-Universität München in Germany and has made significant contributions to medical and neuroscience research. Their work primarily focuses on dementia, Alzheimer's disease, and neurodegenerative disorders, with a substantial number of publications dedicated to these areas.

Their research spans several main fields of study, including:

Medicine
Neuroscience

Within these broad fields, Buerger's work delves into specific subfields such as:

Psychiatry and Mental health
Physiology
Cognitive Neuroscience
Neurology
Radiology, Nuclear Medicine and Imaging

The topics covered in their research reflect a focus on neurodegeneration and brain function, including:

Dementia and Cognitive Impairment Research
Alzheimer's disease research and treatments
Functional Brain Connectivity Studies
Neuroinflammation and Neurodegeneration Mechanisms
Advanced Neuroimaging Techniques and Applications
Neurological Disease Mechanisms and Treatments
Nutritional Studies and Diet

Buerger has published extensively in a range of scientific venues, with frequent publications in:

Alzheimer's & Dementia
bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's Research & Therapy
Journal of Alzheimer's Disease
Neurology

A selection of recent papers includes the following:

"Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases," 2021, Science Translational Medicine
"Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease," 2020, Science Advances
"Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age," 2021, Neurology
"Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals," 2021, Alzheimer's Research & Therapy
"Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease," 2021, Brain

Collaborative work is a notable aspect of Buerger's research, with frequent coauthors including:

Oliver Peters
Annika Spottke
Robert Perneczky
Anja Schneider
Josef Priller

Best Publications

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski

737
Citations
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Henryk Barthel;Hermann-Josef Gertz;Stefan Dresel;Oliver Peters

650
Citations
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Harald Hampel;Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel

592
Citations
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

H. Hampel;S. J. Teipel;T. Fuchsberger;N. Andreasen

399
Citations
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel;Tero Tapiola

360
Citations
Reduced levels of amyloid β-peptide antibody in Alzheimer disease

Y. Du;R. Dodel;H. Hampel;K. Buerger

355
Citations
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.

K. Buerger;S. J. Teipel;Ray Zinkowski;K. Blennow

345
Citations
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

Nobuo Itoh;Hiroyuki Arai;Katsuya Urakami;Koichi Ishiguro

331
Citations
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Itziar de Rojas;Itziar de Rojas;Sonia Moreno-Grau;Sonia Moreno-Grau;Niccolo Tesi;Benjamin Grenier-Boley

318
Citations
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

Frank Jessen;Frank Jessen;Annika Spottke;Annika Spottke;Henning Boecker;Henning Boecker;Frederic Brosseron

263
Citations
Effects of aging on default mode network activity in resting state fMRI: Does the method of analysis matter?

W. Koch;Stefan J. Teipel;Sophia Mueller;Katharina Buerger

255
Citations
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases.

Xianyuan Xiang;Xianyuan Xiang;Karin Wind;Karin Wind;Thomas Wiedemann;Tanja Blume;Tanja Blume

247
Citations
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Richard Dodel;Axel Rominger;Peter Bartenstein;Frederik Barkhof

245
Citations
Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease

Richard Dodel;Harald Hampel;Candan Depboylu;Suizhen Lin

243
Citations
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum

Philine Schneider;Harald Hampel;Harald Hampel;Katharina Buerger

213
Citations
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

Russell Kohnken;Katharina Buerger;Raymond Zinkowski;Caudill Miller

208
Citations
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

M. Ewers;K. Buerger;S. J. Teipel;P. Scheltens

199
Citations
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Annika Olsson;Kina Höglund;Magnus Sjögren;Niels Andreasen

183
Citations
Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.

Verena C. Buschert;Uwe Friese;Stefan J. Teipel;Philine Schneider

180
Citations
EFNS‐ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

Reinhold Schmidt;Edith Hofer;F. H. Bouwman;K. Buerger

168
Citations
Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.

K. Buerger;M. Ewers;N. Andreasen;R. Zinkowski

87
Citations